Friday, July 31, 2026

Trump Welcomes Proposal for Three-Way Meeting With Kim and Lee at APEC

The APEC summit may offer a diplomatic chance for Kim Jong Un, but his attendance seems unlikely amid complex North Korean dynamics.

New Feed Additives: Freshwater Microalgae Enhance Broiler Immunity and Gut Bacteria

South Korean research shows freshwater microalgae can enhance intestinal health in broiler chickens, suggesting potential as a feed additive.

Revolutionary Battery Technology: KAIST Develops Non-Destructive Measurement for EV Lithium-Ion Electrode Thickness

South Korean researchers developed a non-destructive method to measure battery electrode thickness, enhancing safety in electric vehicles.

Tag: solid tumors

Curocell’s RIMQARTO®: The First CAR-T Therapy in Korea, with Plans for Global Release

Curocell aims to lead in CAR-T therapies with RIMQARTO's approval, focusing on solid tumors and global expansion strategies.

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

ABL209 Receives FDA Approval: What This Dual Antibody ADC Means for Cancer Treatment

ABL Bio receives FDA approval for ABL209, a bispecific antibody-drug conjugate, advancing ADC development for solid tumors.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

Top News

- Our Sponsors Ad -

Follow us